Richard E. Lowenthal, President and CEO of ARS Pharmaceuticals ($SPRY), made one open market sale of company shares in the last year, totaling $724 thousand. His most recent sale occurred on August 21, 2025. Among 11,700 insiders with sales, this ranks fifth-sixth fifty-seventh for amount sold, well below the average of $8.6 million across 6.4 transactions per seller. He reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | A | Stock Option (right to buy) | 240000 | $0.00 | 240,000.0000 | 98,807,600 | 9999.99% | 0.24% |
| Jan. 2, 2026 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | A | Stock option (right to buy) | 875000 | $0.00 | 875,000.0000 | 98,807,600 | 9999.99% | 0.89% |
| Aug. 21, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $14.49 | 11,303,141.0000 | 102,390,828 | 0.44% | 0.05% |
| Jan. 2, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | A | Stock option (right to buy) | 767600 | $0.00 | 767,600.0000 | 102,390,828 | 9999.99% | 0.75% |
| Jan. 2, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | A | Stock Option (right to buy) | 261900 | $0.00 | 261,900.0000 | 102,390,828 | 9999.99% | 0.26% |
| Dec. 17, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $11.67 | 11,403,141.0000 | 97,032,331 | 0.44% | 0.05% |
| Dec. 17, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $11.67 | 11,403,141.0000 | 97,032,331 | 0.44% | 0.05% |
| Dec. 10, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $13.17 | 11,503,141.0000 | 97,032,331 | 0.43% | 0.05% |
| Dec. 10, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $13.16 | 11,503,141.0000 | 97,032,331 | 0.43% | 0.05% |
| Dec. 6, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | M | Common Stock | 11876 | $8.42 | 11,603,141.0000 | 97,032,331 | 0.10% | 0.01% |
| Dec. 6, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | M | Common Stock | 13789 | $1.44 | 11,591,265.0000 | 97,032,331 | 0.12% | 0.01% |
| Dec. 6, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | M | Common Stock | 11876 | $8.42 | 11,603,141.0000 | 97,032,331 | 0.10% | 0.01% |
| Dec. 6, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | M | Stock Option (right to buy) | 11876 | $0.00 | 1,426,248.0000 | 97,032,331 | 0.83% | 0.01% |
| Dec. 6, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | M | Stock Option (right to buy) | 13789 | $0.00 | 1,108,808.0000 | 97,032,331 | 1.23% | 0.01% |
| Dec. 6, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | M | Stock Option (right to buy) | 11876 | $0.00 | 1,426,248.0000 | 97,032,331 | 0.83% | 0.01% |
| Nov. 19, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $13.95 | 11,565,600.0000 | 97,032,331 | 0.43% | 0.05% |
| Nov. 19, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $13.95 | 11,565,600.0000 | 97,032,331 | 0.43% | 0.05% |
| Nov. 12, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 4876 | $17.64 | 11,665,600.0000 | 97,032,331 | 0.04% | 0.01% |
| Nov. 12, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 4955 | $17.64 | 11,665,600.0000 | 97,032,331 | 0.04% | 0.01% |
| Nov. 12, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 45124 | $16.76 | 11,670,476.0000 | 97,032,331 | 0.39% | 0.05% |
| Nov. 12, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 45045 | $16.76 | 11,670,555.0000 | 97,032,331 | 0.38% | 0.05% |
| Oct. 15, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 1450 | $15.25 | 11,765,600.0000 | 97,032,331 | 0.01% | 0.00% |
| Oct. 15, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 48550 | $14.86 | 11,767,050.0000 | 97,032,331 | 0.41% | 0.05% |
| Oct. 15, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $14.88 | 11,765,600.0000 | 97,032,331 | 0.42% | 0.05% |
| Oct. 8, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $13.83 | 11,865,600.0000 | 97,032,331 | 0.42% | 0.05% |
| Oct. 8, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $13.83 | 11,865,600.0000 | 97,032,331 | 0.42% | 0.05% |
| Sept. 17, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $12.93 | 11,965,600.0000 | 95,215,322 | 0.42% | 0.05% |
| Sept. 17, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $12.93 | 11,965,600.0000 | 95,215,322 | 0.42% | 0.05% |
| Sept. 10, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $11.50 | 12,065,600.0000 | 95,215,322 | 0.41% | 0.05% |
| Sept. 10, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $11.50 | 12,065,600.0000 | 95,215,322 | 0.41% | 0.05% |
| Aug. 20, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 36216 | $14.76 | 12,179,384.0000 | 95,215,322 | 0.30% | 0.04% |
| Aug. 20, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 11523 | $15.62 | 12,167,861.0000 | 95,215,322 | 0.09% | 0.01% |
| Aug. 20, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 2261 | $16.25 | 12,165,600.0000 | 95,215,322 | 0.02% | 0.00% |
| Aug. 20, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 35944 | $14.76 | 12,179,656.0000 | 95,215,322 | 0.29% | 0.04% |
| Aug. 20, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 11756 | $15.61 | 12,167,900.0000 | 95,215,322 | 0.10% | 0.01% |
| Aug. 20, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 2300 | $16.26 | 12,165,600.0000 | 95,215,322 | 0.02% | 0.00% |
| Aug. 13, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 35363 | $12.77 | 12,265,600.0000 | 95,215,322 | 0.29% | 0.04% |
| Aug. 13, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 14599 | $11.78 | 12,301,001.0000 | 95,215,322 | 0.12% | 0.02% |
| Aug. 13, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 35401 | $12.76 | 12,265,600.0000 | 95,215,322 | 0.29% | 0.04% |
| Aug. 13, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 14637 | $11.77 | 12,300,963.0000 | 95,215,322 | 0.12% | 0.02% |
| July 16, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $11.40 | 12,365,600.0000 | 95,215,322 | 0.40% | 0.05% |
| July 16, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $11.40 | 12,365,600.0000 | 95,215,322 | 0.40% | 0.05% |
| July 9, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $9.62 | 12,465,600.0000 | 95,215,322 | 0.40% | 0.05% |
| July 9, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $9.62 | 12,465,600.0000 | 95,215,322 | 0.40% | 0.05% |
| June 12, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 47834 | $9.15 | 12,565,600.0000 | 95,215,322 | 0.38% | 0.05% |
| June 11, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 2166 | $9.00 | 12,613,434.0000 | 95,215,322 | 0.02% | 0.00% |
| June 12, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 48028 | $9.14 | 12,565,600.0000 | 95,215,322 | 0.38% | 0.05% |
| June 11, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 1972 | $9.00 | 12,613,628.0000 | 95,215,322 | 0.02% | 0.00% |
| May 15, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 2766 | $9.04 | 14,352,143.0000 | 95,215,322 | 0.02% | 0.00% |
| May 14, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 2873 | $9.01 | 14,354,920.0000 | 95,215,322 | 0.02% | 0.00% |
| May 14, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 2884 | $9.01 | 14,354,909.0000 | 95,215,322 | 0.02% | 0.00% |
| May 15, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 2381 | $9.05 | 14,307,793.0000 | 95,215,322 | 0.02% | 0.00% |
| May 16, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 44746 | $9.06 | 14,307,793.0000 | 95,215,322 | 0.31% | 0.05% |
| May 16, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 44350 | $9.06 | 14,307,793.0000 | 95,215,322 | 0.31% | 0.05% |
| May 7, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $9.34 | 12,765,600.0000 | 95,215,322 | 0.39% | 0.05% |
| May 7, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $9.34 | 12,765,600.0000 | 95,215,322 | 0.39% | 0.05% |
| April 23, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | M | Common Stock | 82733 | $0.84 | 12,817,340.0000 | 95,215,322 | 0.65% | 0.09% |
| April 23, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | M | Common Stock | 48260 | $1.44 | 12,865,600.0000 | 95,215,322 | 0.38% | 0.05% |
| April 23, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | M | Stock Option (right to buy) | 82733 | $0.00 | 0.0000 | 95,215,322 | 100.00% | 0.09% |
| April 23, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | M | Stock Option (right to buy) | 48260 | $0.00 | 34,473.0000 | 95,215,322 | 58.33% | 0.05% |
| April 19, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | M | Stock Option (right to buy) | 119047 | $0.00 | 117,333.0000 | 95,215,322 | 50.36% | 0.13% |
| April 19, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | M | Stock Option (right to buy) | 69444 | $0.00 | 166,936.0000 | 95,215,322 | 29.38% | 0.07% |
| April 19, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | M | Common Stock | 69444 | $1.44 | 12,734,607.0000 | 95,215,322 | 0.55% | 0.07% |
| April 19, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | M | Common Stock | 119047 | $0.84 | 12,665,163.0000 | 95,215,322 | 0.95% | 0.13% |
| April 16, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $9.28 | 12,546,116.0000 | 95,215,322 | 0.40% | 0.05% |
| April 16, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $9.28 | 12,546,116.0000 | 95,215,322 | 0.40% | 0.05% |
| April 9, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $9.28 | 12,646,116.0000 | 95,215,322 | 0.39% | 0.05% |
| April 9, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $9.28 | 12,646,116.0000 | 95,215,322 | 0.39% | 0.05% |
| March 25, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 47632 | $9.12 | 12,746,116.0000 | 95,215,322 | 0.37% | 0.05% |
| March 22, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 1326 | $9.01 | 12,793,748.0000 | 95,215,322 | 0.01% | 0.00% |
| March 22, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 1017 | $9.03 | 12,793,751.0000 | 95,215,322 | 0.01% | 0.00% |
| March 25, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 47635 | $9.12 | 12,746,116.0000 | 95,215,322 | 0.37% | 0.05% |
| March 21, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 100 | $9.00 | 12,843,726.0000 | 95,215,322 | 0.00% | 0.00% |
| March 19, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 976 | $9.03 | 12,844,098.0000 | 95,215,322 | 0.01% | 0.00% |
| March 19, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 942 | $9.04 | 12,843,826.0000 | 95,215,322 | 0.01% | 0.00% |
| March 21, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 372 | $9.00 | 12,843,726.0000 | 95,215,322 | 0.00% | 0.00% |
| March 14, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 239 | $9.00 | 12,894,577.0000 | 95,215,322 | 0.00% | 0.00% |
| March 13, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 1500 | $9.00 | 12,894,616.0000 | 95,215,322 | 0.01% | 0.00% |
| March 13, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 1300 | $9.00 | 12,894,816.0000 | 95,215,322 | 0.01% | 0.00% |
| March 14, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 205 | $9.00 | 12,894,411.0000 | 95,215,322 | 0.00% | 0.00% |
| March 15, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 48295 | $9.14 | 12,846,116.0000 | 95,215,322 | 0.37% | 0.05% |
| March 15, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 48461 | $9.14 | 12,846,116.0000 | 95,215,322 | 0.38% | 0.05% |
| Feb. 29, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 800 | $9.02 | 12,946,116.0000 | 95,215,322 | 0.01% | 0.00% |
| Feb. 29, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 1982 | $9.01 | 12,946,116.0000 | 95,215,322 | 0.02% | 0.00% |
| Feb. 29, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 1000 | $9.02 | 12,946,116.0000 | 95,215,322 | 0.01% | 0.00% |
| Feb. 28, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 25456 | $9.02 | 14,722,648.0000 | 95,215,322 | 0.17% | 0.03% |
| Feb. 28, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 49019 | $9.02 | 14,722,648.0000 | 95,215,322 | 0.33% | 0.05% |
| Feb. 28, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 24303 | $9.02 | 14,722,648.0000 | 95,215,322 | 0.16% | 0.03% |
| Feb. 26, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 100 | $9.01 | 14,748,104.0000 | 95,215,322 | 0.00% | 0.00% |
| Feb. 26, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 500 | $9.01 | 14,771,667.0000 | 95,215,322 | 0.00% | 0.00% |
| Feb. 26, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 100 | $9.01 | 14,722,648.0000 | 95,215,322 | 0.00% | 0.00% |
| May 17, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | President and CEO | G | Common Stock | 1050000 | $0.00 | 13,049,376.0000 | 0 | 8.75% | 0.00% |
| Jan. 2, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | President and CEO | A | Stock option (right to buy) | 880000 | $0.00 | 1,180,000.0000 | 95,215,322 | 293.33% | 0.92% |
| Jan. 2, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | President and CEO | A | Stock option (right to buy) | 300000 | $0.00 | 1,180,000.0000 | 95,215,322 | 34.09% | 0.32% |
| May 17, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | President and CEO | G | Common Stock | 1050000 | $0.00 | 13,049,376.0000 | 0 | 7.45% | 0.00% |
| May 17, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | President and CEO | G | Common Stock | 1050000 | $0.00 | 11,999,376.0000 | 0 | 9.59% | 0.00% |
| May 17, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | President and CEO | G | Common Stock | 1050000 | $0.00 | 13,049,376.0000 | 0 | 7.45% | 0.00% |
| Jan. 3, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | President and CEO | A | Stock option (right to buy) | 1100000 | $0.00 | 1,450,000.0000 | 0 | 314.29% | 0.00% |
| Jan. 3, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Lowenthal Richard E | President and CEO | A | Stock option (right to buy) | 350000 | $0.00 | 1,450,000.0000 | 0 | 31.82% | 0.00% |